CD4 and neoplasm: In addition, HIF-1ɑ also promotes a tumor-tolerant environment, reducing the infiltration of CD4+ and CD8+ T-lymphocytes and tumor-associated macrophages (TAMs) [40], increasing the differentiation of T-lymphocytes into T-helper 17 (TH17) cells [41] and modulating TAM polarization [42].